CRISPR Therapeutics AG
Closed
SectorHealthcare
55.61 -1.01
Overview
Share price change
24h
Min
55.3
Max
57.03
Income | -91M -214M |
|---|---|
Sales | 8.7M 10M |
EPS | -0.94 |
Profit margin | -2,102.79 |
Employees | 393 |
EBITDA | 7.3M -110M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +31.81% upside |
Next Earnings | 9 lis 2026 |
|---|
Market Cap | 907M 5.5B |
|---|---|
Previous open | 56.62 |
Previous close | 55.61 |
News Sentiment
By Acuity
50%
50%
149 / 339 Ranking in Healthcare
CRISPR Therapeutics AG Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
CRISPR Therapeutics AG Forecast
Price Target
By TipRanks
12 Months Forecast
Average 74.46 USD 31.81%
High 110 USD
Low 45 USD
Based on 14 Wall Street analysts offering 12 month price targets forCRISPR Therapeutics AG - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$